EUVIMEDEUVIMED entdecken
Open Access

Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itching

Yuya Hoshino, Kazuyoshi Kirima, Naoya Arichika, Yusuke Kakumoto, Masafumi Shibamori, Satoshi Matsumoto, Hidetaka Hiyama

Experimental Animals · 2025

DOI: 10.1538/expanim.24-0088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2025. Verfasst von Yuya Hoshino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Investigative Toxicology, Preclinical Research, Tokushima Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., 463-10 K…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Pruritus, Inflammation, Skin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic skin disease that causes itching and is characterized by recurrent flares and remissions. The interactions among type 2 inflammation, skin barrier dysfunction, and pruritus play important roles in the pathogenesis of AD. AD symptoms persist for a long period; thus, it is desirable to have disease models that reproduce a prolonged AD-like phenotype. Although MC903-induced AD model mice reportedly exhibit type 2 inflammation, skin barrier dysfunction, and pruritus, the effects of long-term application of MC903 on the changes in these symptoms over time are not fully understood. To clarify this point, we conducted a long-term time course analysis of these symptoms by applying MC903 to the ears of mice every other day for four weeks. Increased ear thickness, transepidermal water loss, number of scratching events, and serum IgE levels were observed in the MC903 model. Histological analysis revealed the infiltration of granulocytes and CD3-positive T cells and an increase in mast cells in the dermis. Furthermore, analyses of mRNA and protein expression in ear tissue revealed increased expression of thymic stromal lymphopoietin, IL-4, IL-13, and IL-33, which are involved in type 2 inflammation. All these changes were observed within two weeks after the initial application of MC903 and thereafter persisted throughout the experimental period. In conclusion, our data indicate that the long-term application of MC903 prolongs the duration of the three major symptoms of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPruritusInflammationSkinAnimalsDisease Models, AnimalCytokinesMice, Inbred BALB CImmunoglobulin EMiceTime FactorsFemaleThymic Stromal LymphopoietinMast Cells

Stichwörter der Autor:innen

MC903atopic dermatitisscratchingskin barrier dysfunctiontype 2 inflammation

Substanzen

CytokinesImmunoglobulin EThymic Stromal Lymphopoietin

Autor:innen und Institutionen

  • Department of Investigative Toxicology, Preclinical Research, Tokushima Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-0192, Japan.
  • Department of Lead Discovery Research, Tokushima Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-0192, Japan.
  • Immunology and Allergy Laboratory, Immunology Unit, Department of Medical Innovations, Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., 5-1-35 Saito-aokita, Minoh, Osaka 562-0029, Japan.

Zitieren

APA

Hoshino, Y., Kirima, K., Arichika, N., Kakumoto, Y., Shibamori, M., Matsumoto, S., & Hiyama, H. (2025). Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itching. Experimental Animals. https://doi.org/10.1538/expanim.24-0088

Vancouver

Hoshino Y, Kirima K, Arichika N, Kakumoto Y, Shibamori M, Matsumoto S, et al. Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itching. Experimental Animals. 2025. doi:10.1538/expanim.24-0088

BibTeX
@article{Hoshino2025,
  author = {Hoshino, Yuya and Kirima, Kazuyoshi and Arichika, Naoya and Kakumoto, Yusuke and Shibamori, Masafumi and Matsumoto, Satoshi and Hiyama, Hidetaka},
  title = {Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itching},
  journal = {Experimental Animals},
  year = {2025},
  doi = {10.1538/expanim.24-0088}
}
Kostenlos starten →